Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effects of BRG1 depletion in the proliferation of lung cancer cells with amplification at the MYC family of genes and in MAX-deficient cells, after reconstitution.

Published byIda Lie Modified over 6 years ago

Similar presentations

Presentation on theme: "Effects of BRG1 depletion in the proliferation of lung cancer cells with amplification at the MYC family of genes and in MAX-deficient cells, after reconstitution."— Presentation transcript:

1 Effects of BRG1 depletion in the proliferation of lung cancer cells with amplification at the MYC family of genes and in MAX-deficient cells, after reconstitution of MAX. A, MTT assay to determine viability, after depleting BRG1 and in the scramble (scr) co... Effects of BRG1 depletion in the proliferation of lung cancer cells with amplification at the MYC family of genes and in MAX-deficient cells, after reconstitution of MAX. A, MTT assay to determine viability, after depleting BRG1 and in the scramble (scr) control, of cells carrying amplification of MYC (H446, H460, and H82), MYCN (H69), or MYCL (HCC33 and H1963). Lines, the number of viable cells relative to the total number of cells at 0 hours. Error bars, SD. NS, not significant; *, P < 0.05; **, P < B, left, MTT assays of MAX-deficient cells carrying the indicated constructs. Right, images of the MTT assay of Lu134 cells. Octavio A. Romero et al. Cancer Discovery 2014;4: ©2014 by American Association for Cancer Research

Download ppt "Effects of BRG1 depletion in the proliferation of lung cancer cells with amplification at the MYC family of genes and in MAX-deficient cells, after reconstitution."

Similar presentations

A. B. BxPC-3 PANC-1 140 48 h 140 72 h 120 24 h 120 96 h 100 48 h 100 *** * 72 h Cell viability (%) 80 *** *** Cell viability (%) 80 *** *** 60 *** ***

A. B. BxPC-3 PANC h h h h h 100 *** * 72 h Cell viability (%) 80 *** *** Cell viability (%) 80 *** *** 60 *** ***
Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. A,

Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. A,
CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.

CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
miR-133a positively regulated p53/p21 pathway.

miR-133a positively regulated p53/p21 pathway.
Dual-Luciferase Activation Assay with Potential Targets of ZmbZIP22.

Dual-Luciferase Activation Assay with Potential Targets of ZmbZIP22.
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.

NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
A B Supplementary Figure 3

A B Supplementary Figure 3
Recombinant OPCML protein effect in vitro.

Recombinant OPCML protein effect in vitro.
BV6 increases tumor burden in bone.

BV6 increases tumor burden in bone.
Bortezomib sensitivity correlates with basal NF-κB activity in KP lung adenocarcinoma cell lines. Bortezomib sensitivity correlates with basal NF-κB activity.

Bortezomib sensitivity correlates with basal NF-κB activity in KP lung adenocarcinoma cell lines. Bortezomib sensitivity correlates with basal NF-κB activity.
Cytotoxicity of MSP samples to normal and cancer cell lines.

Cytotoxicity of MSP samples to normal and cancer cell lines.
Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.

Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.
A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.

A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.
Knockdown of DAO inhibits DNA damage–induced senescence.

Knockdown of DAO inhibits DNA damage–induced senescence.
AMPK induces VEGF-A production by upregulating ERK signaling.

AMPK induces VEGF-A production by upregulating ERK signaling.
CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture. CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture.

CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture. CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture.
ROS induction and ATR inhibition synergize in inducing multiple myeloma (MM) cell death. ROS induction and ATR inhibition synergize in inducing multiple.

ROS induction and ATR inhibition synergize in inducing multiple myeloma (MM) cell death. ROS induction and ATR inhibition synergize in inducing multiple.
The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL

The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL
Chloroquine (CQ) improves tumor cell kill when used in combination with vemurafenib and chemotherapy in BRAFV600E-mutant cells. Chloroquine (CQ) improves.

Chloroquine (CQ) improves tumor cell kill when used in combination with vemurafenib and chemotherapy in BRAFV600E-mutant cells. Chloroquine (CQ) improves.
TDP1 knockdown increases the sensitivity of rhabdomyosarcoma cell lines to CPT treatment. TDP1 knockdown increases the sensitivity of rhabdomyosarcoma.

TDP1 knockdown increases the sensitivity of rhabdomyosarcoma cell lines to CPT treatment. TDP1 knockdown increases the sensitivity of rhabdomyosarcoma.

Similar presentations

Ads by Google